BNP Paribas Financial Markets’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.38M | Buy |
29,099
+2,112
| +8% | +$111K | ﹤0.01% | 2913 |
|
|
2025
Q4 | $1.42M | Buy |
26,987
+1,961
| +8% | +$117K | ﹤0.01% | 2876 |
|
|
2025
Q3 | $1.62M | Buy |
25,026
+5,769
| +30% | +$331K | ﹤0.01% | 2767 |
|
|
2025
Q2 | $937K | Buy |
19,257
+842
| +5% | +$32.6K | ﹤0.01% | 2947 |
|
|
2025
Q1 | $627K | Sell |
18,415
-64,579
| -78% | -$2.74M | ﹤0.01% | 3052 |
|
|
2024
Q4 | $3.27M | Sell |
82,994
-4,962
| -6% | -$234K | ﹤0.01% | 2062 |
|
|
2024
Q3 | $4.13M | Sell |
87,956
-48,377
| -35% | -$2.45M | ﹤0.01% | 1615 |
|
|
2024
Q2 | $7.36M | Sell |
136,333
-12,609
| -8% | -$729K | 0.01% | 1234 |
|
|
2024
Q1 | $10.2M | Buy |
148,942
+106,652
| +252% | +$7.63M | 0.01% | 1082 |
|
|
2023
Q4 | $2.65M | Sell |
42,290
-87,212
| -67% | -$4.82M | ﹤0.01% | 1785 |
|
|
2023
Q3 | $5.88M | Buy |
129,502
+76,675
| +145% | +$3.96M | 0.01% | 1167 |
|
|
2023
Q2 | $2.97M | Buy |
52,827
+5,150
| +11% | +$292K | 0.01% | 1528 |
|
|
2023
Q1 | $2.16M | Sell |
47,677
-42,591
| -47% | -$2.07M | ﹤0.01% | 1767 |
|
|
2022
Q4 | $3.67M | Buy |
90,268
+29,143
| +48% | +$1.55M | 0.01% | 1469 |
|
|
2022
Q3 | $3.99M | Buy |
61,125
+55,656
| +1,018% | +$4.03M | 0.01% | 1485 |
|
|
2022
Q2 | $332K | Sell |
5,469
-16,424
| -75% | -$966K | ﹤0.01% | 2870 |
|
|
2022
Q1 | $1.37M | Sell |
21,893
-3,611
| -14% | -$227K | ﹤0.01% | 2096 |
|
|
2021
Q4 | $1.93M | Buy |
25,504
+24,331
| +2,074% | +$2.13M | ﹤0.01% | 2057 |
|
|
2021
Q3 | $131K | Buy |
1,173
+13
| +1% | +$1.63K | ﹤0.01% | 3181 |
|
|
2021
Q2 | $188K | Buy |
1,160
+569
| +96% | +$69.2K | ﹤0.01% | 2882 |
|
|
2021
Q1 | $72K | Sell |
591
-14,056
| -96% | -$2.12M | ﹤0.01% | 3494 |
|
|
2020
Q4 | $2.24M | Buy |
14,647
+7,514
| +105% | +$888K | 0.01% | 1571 |
|
|
2020
Q3 | $597K | Buy |
7,133
+808
| +13% | +$71.7K | ﹤0.01% | 2110 |
|
|
2020
Q2 | $465K | Sell |
6,325
-32,029
| -84% | -$1.87M | ﹤0.01% | 2133 |
|
|
2020
Q1 | $1.63M | Buy |
38,354
+37,149
| +3,083% | +$1.92M | 0.01% | 1607 |
|
|
2019
Q4 | $73.4K | Sell |
1,205
-23,577
| -95% | -$1.29M | ﹤0.01% | 3445 |
|
|
2019
Q3 | $1.02M | Buy |
24,782
+23,911
| +2,745% | +$1.14M | ﹤0.01% | 1827 |
|
|
2019
Q2 | $41K | Buy |
+871
| New | +$34.8K | ﹤0.01% | 3540 |
|
Other funds holding CRSP
AIM
OAG
GP
SOCM
